Related Experiment Video

Updated: Jun 19, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Trials review: cardiovascular outcome with intensive glycemic control and implications for patients with type 2

Siobhan H M Brown1, Ahmed H Abdelhafiz

  • 1Rotherham General Hospital, Rotherham, UK.

Postgraduate Medicine
|October 13, 2009
PubMed

Insights

Intensive glucose control reduces microvascular issues in diabetes but its effect on cardiovascular events remains unclear. This review examines trials to clarify benefits for type 2 diabetes patients, especially older adults.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Diseases

Background:

  • Hyperglycemia in diabetes mellitus is linked to microvascular and macrovascular complications.
  • Intensive glucose control effectively reduces microvascular complications.
  • Cardiovascular disease is the primary cause of mortality in type 2 diabetes patients.

Purpose of the Study:

  • To review intervention trials on intensive glucose control in type 2 diabetes.
  • To evaluate the impact of intensive glucose control on cardiovascular events.
  • To discuss recommendations for managing blood glucose in adults with type 2 diabetes.

Main Methods:

  • Review of published intervention trials.
  • Analysis of outcomes related to intensive glucose control.
  • Synthesis of evidence on cardiovascular events and glycemic targets.

Main Results:

  • Intensive glucose control is associated with reduced microvascular complications.
  • The effect of intensive glucose control on cardiovascular events is not definitively established.
  • Benefits may vary in heterogeneous populations, including older adults.

Conclusions:

  • While intensive glucose control benefits microvascular health, its role in preventing cardiovascular events in type 2 diabetes requires further clarification.
  • Evidence synthesis suggests cautious application in older or complex patient groups.
  • Recommendations for glycemic management should consider individual patient factors and cardiovascular risk.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...